Document is current
Any future updates will be listed below
-
Authors
Kahveci, Abdulvahap https://orcid.org/0000-0002-2611-2372
Sıdzhımlı, Yuzlem Gyuner https://orcid.org/0000-0002-7707-8741
Güneş, Seçilay https://orcid.org/0000-0002-1231-7094
Gümüştepe, Alper https://orcid.org/0000-0003-1585-2540
Baysan, Caner https://orcid.org/0000-0002-7675-1391
Ataman, Şebnem https://orcid.org/0000-0003-3570-3825
- License Information
-
More Information
Article History
Received: 29 May 2022
Accepted: 12 August 2022
First Online: 20 August 2022
Declarations
:
: All authors have no conflict of interest.
: During the study, the World Medical Association Helsinki Declaration and Good Clinical Practices Guidelines were followed. This study was approved by the local ethics committee (Protocol number: İ9-559-20). Reporting of this trial was conducted according to the STROBE (Strengthening the reporting of observational studies in epidemiology) checklist. This study has been presented as an oral presentation at the Turkish League against Rheumatism (TLAR) 2021 congress and has been selected as the second-best study.
